Duobrii in Combination With Biologics

Inclusion Criteria:

1. Male or female adult ≥ 18 years of age;

2. Diagnosis of chronic plaque-type

3. Psoriasis affecting 2%-10% BSA

4. Patient is being treated with biologic therapy for a minimum of 24 weeks

5. Able and willing to give written informed consent prior to performance of anystudy-related procedures

Exclusion Criteria:

1. Psoriasis affecting ˂2% or >10% BSA

2. Patient not receiving a biologic agent, or receiving biologic agent <24weeks

3. Received treatment with any topical antipsoriatic drug product within 14 days prior tothe Baseline visit.

4. Has previously used DUOBRII